SBIO
Fund Stats as of 12/12/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $32.37
Last Trade Price $32.35
NAV $32.40
NAV Change $0.53
Total Net Assets $210,617,091
Total Market Value $210,025,175
Premium/Discount(%) -0.09%
Difference ($) $-0.03
Volume 33,361
Shares Outstanding 6,500,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 112 total, as of 12/12/2018, subject to change

SecuritySymbolWeight
Galapagos NVGLPG4.11%
Amarin Corp. PLCAMRN3.69%
United Therapeutics Corp.UTHR3.66%
Hutchison China MediTech Ltd.HCM3.31%
Loxo Oncology Inc.LOXO3.19%
GW Pharmaceuticals PLCGWPH2.67%
Taro Pharmaceutical Industries Ltd.TARO2.65%
Immunomedics Inc.IMMU2.63%
FibroGen Inc.FGEN2.57%
Array BioPharma Inc.ARRY2.56%
Horizon Pharma PLCHZNP2.47%
Intercept Pharmaceuticals Inc.ICPT2.45%
Agios Pharmaceuticals Inc.AGIO2.44%
Emergent BioSolutions Inc.EBS2.42%
Ligand Pharmaceuticals Inc.LGND2.34%
Akcea Therapeutics Inc.AKCA2.07%
Endo International PLCENDP1.88%
Ascendis Pharma ASASND1.74%
Halozyme Therapeutics Inc.HALO1.70%
Global Blood Therapeutics Inc.GBT1.69%
MyoKardia Inc.MYOK1.68%
Acceleron Pharma Inc.XLRN1.65%
Arena Pharmaceuticals Inc.ARNA1.58%
Heron Therapeutics Inc.HRTX1.56%
Supernus Pharmaceuticals Inc.SUPN1.46%
Pacira Pharmaceuticals Inc.PCRX1.45%
Atara Biotherapeutics Inc.ATRA1.44%
Aerie Pharmaceuticals Inc.AERI1.38%
Madrigal Pharmaceuticals Inc.MDGL1.30%
AnaptysBio Inc.ANAB1.29%
Endocyte Inc.ECYT1.25%
PTC Therapeutics Inc.PTCT1.22%
Ironwood Pharmaceuticals Inc.IRWD1.20%
Theravance Biopharma Inc.TBPH1.16%
Spark Therapeutics Inc.ONCE1.15%
Enanta Pharmaceuticals Inc.ENTA1.09%
Aimmune Therapeutics Inc.AIMT1.03%
Mirati Therapeutics Inc.MRTX1.02%
Insmed Inc.INSM0.91%
G1 Therapeutics Inc.GTHX0.85%
Apellis Pharmaceuticals Inc.APLS0.76%
Intersect ENT Inc.XENT0.73%
Rhythm Pharmaceuticals Inc.RYTM0.72%
Fate Therapeutics Inc.FATE0.67%
Revance Therapeutics Inc.RVNC0.61%
ImmunoGen Inc.IMGN0.61%
Acorda Therapeutics Inc.ACOR0.58%
Radius Health Inc.RDUS0.58%
Vericel Corp.VCEL0.57%
UroGen Pharma Ltd.URGN0.55%
Dynavax Technologies Corp.DVAX0.55%
Omeros Corp.OMER0.52%
Rocket Pharmaceuticals Inc.RCKT0.47%
Assembly Biosciences Inc.ASMB0.46%
MacroGenics Inc.MGNX0.45%
AMAG Pharmaceuticals Inc.AMAG0.45%
Ra Pharmaceuticals Inc.RARX0.41%
Kura Oncology Inc.KURA0.41%
Akorn Inc.AKRX0.41%
Flexion Therapeutics Inc.FLXN0.41%
NuCana PLCNCNA0.40%
ChemoCentryx Inc.CCXI0.39%
Cymabay Therapeutics Inc.CBAY0.39%
Akebia Therapeutics Inc.AKBA0.38%
GlycoMimetics Inc.GLYC0.35%
Dova Pharmaceuticals Inc.DOVA0.33%
Achillion Pharmaceuticals Inc.ACHN0.33%
PDL BioPharma Inc.PDLI0.33%
Epizyme Inc.EPZM0.33%
Five Prime Therapeutics Inc.FPRX0.32%
Odonate Therapeutics Inc.ODT0.32%
Progenics Pharmaceuticals Inc.PGNX0.31%
MediciNova Inc.MNOV0.30%
Corbus Pharmaceuticals Holdings Inc.CRBP0.29%
Kiniksa Pharmaceuticals Ltd.KNSA0.29%
ArQule Inc.ARQL0.28%
CASI Pharmaceuticals Inc.CASI0.28%
resTORbio Inc.TORC0.28%
Voyager Therapeutics Inc.VYGR0.27%
Concert Pharmaceuticals Inc.CNCE0.24%
Minerva Neurosciences Inc.NERV0.23%
Albireo Pharma Inc.ALBO0.23%
Syros Pharmaceuticals Inc.SYRS0.22%
Athersys Inc.ATHX0.21%
Savara Inc.SVRA0.21%
Assertio Therapeutics Inc.ASRT0.21%
Adamas Pharmaceuticals Inc.ADMS0.20%
Aclaris Therapeutics Inc.ACRS0.19%
Catalyst Pharmaceuticals Inc.CPRX0.18%
Aduro Biotech Inc.ADRO0.17%
Tocagen Inc.TOCA0.17%
Strongbridge Biopharma PLCSBBP0.16%
Paratek Pharmaceuticals Inc.PRTK0.16%
Lannett Co. Inc.LCI0.15%
Idera Pharmaceuticals Inc.IDRA0.14%
Calithera Biosciences Inc.CALA0.13%
Allena Pharmaceuticals Inc.ALNA0.13%
Marinus Pharmaceuticals Inc.MRNS0.13%
Ardelyx Inc.ARDX0.11%
Kala Pharmaceuticals Inc.KALA0.11%
Durect Corp.DRRX0.09%
Jounce Therapeutics Inc.JNCE0.09%
Catalyst Biosciences Inc.14888D200.09%
Syndax Pharmaceuticals Inc.SNDX0.09%
Avadel Pharmaceuticals PLCAVDL0.08%
Immune Design Corp.IMDZ0.07%
CTI BioPharma Corp.CTIC0.06%
Aquinox Pharmaceuticals Inc.AQXP0.04%
Clearside Biomedical Inc.CLSD0.03%
Corium International IncCORI-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.38%
Cash and Equivalents0.30%
Total Net Assets 100.00%
Security
Galapagos NV
Amarin Corp. PLC
United Therapeutics Corp.
Hutchison China MediTech Ltd.
Loxo Oncology Inc.
GW Pharmaceuticals PLC
Taro Pharmaceutical Industries Ltd.
Immunomedics Inc.
FibroGen Inc.
Array BioPharma Inc.
Horizon Pharma PLC
Intercept Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Emergent BioSolutions Inc.
Ligand Pharmaceuticals Inc.
Akcea Therapeutics Inc.
Endo International PLC
Ascendis Pharma AS
Halozyme Therapeutics Inc.
Global Blood Therapeutics Inc.
MyoKardia Inc.
Acceleron Pharma Inc.
Arena Pharmaceuticals Inc.
Heron Therapeutics Inc.
Supernus Pharmaceuticals Inc.
Pacira Pharmaceuticals Inc.
Atara Biotherapeutics Inc.
Aerie Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc.
AnaptysBio Inc.
Endocyte Inc.
PTC Therapeutics Inc.
Ironwood Pharmaceuticals Inc.
Theravance Biopharma Inc.
Spark Therapeutics Inc.
Enanta Pharmaceuticals Inc.
Aimmune Therapeutics Inc.
Mirati Therapeutics Inc.
Insmed Inc.
G1 Therapeutics Inc.
Apellis Pharmaceuticals Inc.
Intersect ENT Inc.
Rhythm Pharmaceuticals Inc.
Fate Therapeutics Inc.
Revance Therapeutics Inc.
ImmunoGen Inc.
Acorda Therapeutics Inc.
Radius Health Inc.
Vericel Corp.
UroGen Pharma Ltd.
Dynavax Technologies Corp.
Omeros Corp.
Rocket Pharmaceuticals Inc.
Assembly Biosciences Inc.
MacroGenics Inc.
AMAG Pharmaceuticals Inc.
Ra Pharmaceuticals Inc.
Kura Oncology Inc.
Akorn Inc.
Flexion Therapeutics Inc.
NuCana PLC
ChemoCentryx Inc.
Cymabay Therapeutics Inc.
Akebia Therapeutics Inc.
GlycoMimetics Inc.
Dova Pharmaceuticals Inc.
Achillion Pharmaceuticals Inc.
PDL BioPharma Inc.
Epizyme Inc.
Five Prime Therapeutics Inc.
Odonate Therapeutics Inc.
Progenics Pharmaceuticals Inc.
MediciNova Inc.
Corbus Pharmaceuticals Holdings Inc.
Kiniksa Pharmaceuticals Ltd.
ArQule Inc.
CASI Pharmaceuticals Inc.
resTORbio Inc.
Voyager Therapeutics Inc.
Concert Pharmaceuticals Inc.
Minerva Neurosciences Inc.
Albireo Pharma Inc.
Syros Pharmaceuticals Inc.
Athersys Inc.
Savara Inc.
Assertio Therapeutics Inc.
Adamas Pharmaceuticals Inc.
Aclaris Therapeutics Inc.
Catalyst Pharmaceuticals Inc.
Aduro Biotech Inc.
Tocagen Inc.
Strongbridge Biopharma PLC
Paratek Pharmaceuticals Inc.
Lannett Co. Inc.
Idera Pharmaceuticals Inc.
Calithera Biosciences Inc.
Allena Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc.
Ardelyx Inc.
Kala Pharmaceuticals Inc.
Durect Corp.
Jounce Therapeutics Inc.
Catalyst Biosciences Inc.
Syndax Pharmaceuticals Inc.
Avadel Pharmaceuticals PLC
Immune Design Corp.
CTI BioPharma Corp.
Aquinox Pharmaceuticals Inc.
Clearside Biomedical Inc.
Corium International Inc
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets